mresvia - Search News

UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 years and older. The shot, branded as mRESVIA, is for the prevention of lower respiratory tract disease in older adults,

Business Insider · 3d

Moderna receives MHRA marketing authorization for RSV vaccine

Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for

Vietnam Investment Review on M… · 4d

AIM Vaccine s mRNA RSV Vaccine Approved for U S Clinical Trials

Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd. (a joint stock company incorporated in the People's Republic of China with limited liability) (Stock Code: 6660.HK) HONG KONG,

17don MSN

Moderna is counting on its product pipeline to resuscitate its ailing stock

Moderna Inc.’s stock fell 2.9% early Friday, after the biotech posted a wider-than-expected fourth-quarter loss and offered soft guidance for 2025, offsetting a revenue beat. Cambridge, Mass.-based ...

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now